Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy

Sri Harsha Boppana; Nageswara Rao Dulla; Bryce D. Beutler; Nageshwara Gullapalli; Ratinder Kaur

doi:10.12659/AJCR.932888

17 August 2021 : Case report USA

Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Unexpected drug reaction, Rare disease, Clinical situation which can not be reproduced for ethical reasons

Sri Harsha Boppana^1A*, Nageswara Rao Dulla^2EF, Bryce D. Beutler^3EF, Nageshwara Gullapalli^1ADEFG, Ratinder Kaur^14DE

DOI: 10.12659/AJCR.932888

Am J Case Rep 2021; 22:e932888

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Export

Export Article Citation

Share via email

Share method:

Via email client program

Send me to my email

Content:

Title, authors, link

Title, authors, link, abstract

Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy